<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The relative contribution of secretory IgA, monomeric and polymeric IgA and IgA/secretory component-containing immune complexes was investigated in sera of diabetic patients </plain></SENT>
<SENT sid="1" pm="."><plain>Secretory IgA and immune complexes containing IgA and secretory component seem to participate in the hyper-IgA of patients with Type 2 (non-insulin-dependent) <z:mp ids='MP_0002055'>diabetes</z:mp> only, suggesting an altered hepatic clearance via secretory component receptors on hepatocytes </plain></SENT>
<SENT sid="2" pm="."><plain>In Type 1 (insulin-dependent) <z:mp ids='MP_0002055'>diabetes</z:mp>, the high serum IgA levels might be explained by an increase in IgA production in response to antigenic stimuli </plain></SENT>
<SENT sid="3" pm="."><plain>Evidence is also accumulated that immune complexes containing IgA of mucosal origin may be involved in <z:e sem="disease" ids="C0155765" disease_type="Disease or Syndrome" abbrv="">microangiopathy</z:e> production in Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>